Mirae Asset Global Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1K | Buy |
3,443
+513
| +18% | +$3.29K | ﹤0.01% | 1386 |
|
|
2025
Q1 | $10.7K | Buy |
2,930
+646
| +28% | +$2.36K | ﹤0.01% | 1461 |
|
|
2024
Q4 | $8.84K | Sell |
2,284
-178
| -7% | -$689 | ﹤0.01% | 1528 |
|
|
2024
Q3 | $7.58K | Buy |
2,462
+432
| +21% | +$1.33K | ﹤0.01% | 1507 |
|
|
2024
Q2 | $3.92K | Sell |
2,030
-21,812
| -91% | -$42.1K | ﹤0.01% | 1496 |
|
|
2024
Q1 | $672K | Sell |
23,842
-515
| -2% | -$14.5K | ﹤0.01% | 1757 |
|
|
2023
Q4 | $359K | Buy |
24,357
+103
| +0.4% | +$1.52K | ﹤0.01% | 2119 |
|
|
2023
Q3 | $444K | Buy |
24,254
+905
| +4% | +$16.6K | ﹤0.01% | 1941 |
|
|
2023
Q2 | $504K | Sell |
23,349
-115
| -0.5% | -$2.48K | ﹤0.01% | 1945 |
|
|
2023
Q1 | $688K | Sell |
23,464
-43
| -0.2% | -$1.26K | ﹤0.01% | 1751 |
|
|
2022
Q4 | $869K | Buy |
23,507
+8,622
| +58% | +$319K | ﹤0.01% | 1576 |
|
|
2022
Q3 | $419K | Buy |
+14,885
| New | +$419K | ﹤0.01% | 1979 |
|